echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > Let's get started! The National Health and Wellness Commission on-the-spot inspection of medical clean-up.

    Let's get started! The National Health and Wellness Commission on-the-spot inspection of medical clean-up.

    • Last Update: 2020-10-07
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Recently, the State Health And Safety Commission Comprehensive Supervision Bureau issued "on the implementation of the 2020 health care industry comprehensive supervision and inspection of the collection of clues" said that the National Health and Health Commission is scheduled to work with relevant departments in late September to organize comprehensive supervision and supervision of the health care industry, Beijing, Hebei and other 19 provinces (regions, cities) and Xinjiang Production and Construction Corps on-site inspection.
    Inspectors will focus on the medical and health industry comprehensive supervision system to promote the implementation of the new crown pneumonia epidemic prevention and control, etc. , in the announcement, the National Health and Safety Commission said that through the following complaints to report telephone and mailbox collection clues: lead collection time: September 18 to October 31, 2020.
    Reporting telephone: 010-84088534 (fax) E-mail: ylwshyzhjgdc@163.com clues collection scope includes: commercial bribery in the field of medicine and other unfair competition, medical institutions illegal practice, illegal publication of medical advertising, medical insurance fixed-point medical institutions irregular use of medical insurance funds, public medical institutions have not implemented collection and cancellation of the increase.
    health care commission said that there are representative clues to the problem, the inspection team will be on the ground inspection and verification, timely response to social and public concerns.
    from the lead collection time can be seen, the National Health and Safety Commission's current round of on-the-spot inspections until at least October 31.
    the announcement, the State Health and Safety Commission's Comprehensive Supervision Bureau also held the "2020 Health Care Industry Comprehensive Supervision and Supervision Training Mobilization Meeting."
    Li Bin, deputy director of the National Health and Safety Commission, stressed at the meeting that 2020 is the year when the construction of an integrated supervision system is closed, focusing on the outstanding problems in comprehensive supervision and epidemic prevention and control, and dare to move hard to ensure that inspectors achieve effective results.
    the same time outstanding problems, weak rectification, into the next year's inspection plan, to carry out "look back."
    There have been industry insiders said that this round of nationwide medical clean-up more stringent than in the past, from the above content can be a glimpse of the reasons, 2020 is the year of the construction of a comprehensive regulatory system.
    National medical style construction and rectification, is under way as early as June 5 this year, the National Health and Health Commission, the Ministry of Public Security and other nine departments issued "2020 to correct the field of pharmaceutical purchase and sale and medical services in the wrong wind work points" on the emphasis, serious investigation and punishment of the collection of pharmaceutical supplies enterprise rebate behavior. By the end of
    , led by the National Health And Health Commission, the State Administration of Traditional Chinese Medicine and the State Administration of Medical Insurance, respectively, in accordance with their responsibilities, the State Administration of Market Supervision, the Ministry of Public Security in accordance with their duties, serious investigation and punishment of the collection of pharmaceutical supplies enterprise rebate behavior.
    On the afternoon of July 24, the General Office of the National Health and Safety Commission issued a "notice on the issuance of a special action plan for the construction of the style of the medical industry in 2020", again clear, from July this year until the end of the year, will focus on the treatment of medical personnel to collect kickbacks, pharmaceutical companies illegal marketing and other acts.
    Among them, August-November, is the focus of the medical style construction of publicity and rectification stage - the local health and health administrative departments responsible for investigating and prosecuting the medical institutions and medical personnel at this level of receiving "red envelopes", kickbacks and other irregularities, collect, organize the masses to report clues and in accordance with their duties to investigate or transfer to the relevant departments to investigate.
    the scope of centralized rehabilitation will achieve full coverage of hospitals (including Chinese hospitals and maternal and child health care hospitals) in the jurisdiction, other types of medical institutions (community health service centers (stations), outpatient clinics, clinics) coverage of more than 50%.
    , the country issued a number of requests to carry out their own special corrective action.
    September 16th, the Guangxi Autonomous Region Health Care Commission, the Medical Insurance Bureau of the Autonomous Region and the Chinese Medicine Bureau of the Autonomous Region issued the Notice on the Implementation of the Special Corrective Action on Outstanding Issues in the Medical and Health Field of Guangxi in 2020, proposing the key tasks of special rectification.
    September 14th, the Shanghai Municipal Health and Safety Commission issued two consecutive notices on drug control, calling for the start of the rectification of pharmaceutical purchase and sale and drug rebates.
    The special rectification period in Shanghai will be implemented from September to December 2020 in three stages: (i) the education and self-examination phase (September 2020) ;(2) and the publicity and rectification phase (October-November 2020) ;(thred) assessment and summary phase (December 2020).
    September 3rd, Gansu Provincial Health and Health Commission issued a "Notice on the issuance of a special action plan for the construction of the style of the medical industry in Gansu Province in 2020" requiring serious investigation and punishment of medical institutions practitioners of various kickbacks, collection of commission behavior.
    August 21, the Beijing Municipal Health and Safety Commission issued a "notice on the implementation of the medical industry style construction work special action" clearly focused on publicity and rectification time is September-November 2020.
    firmly punish improper acts such as using their position to facilitate the profit of red envelopes, crack down on illegal and illegal activities in collecting kickbacks, and seriously investigate and punish illegal marketing practices of pharmaceutical products in medical institutions.
    , Henan, Liaoning, Shaanxi, Shandong and Hebei also issued documents calling for inspections of public hospitals.
    The State Health Insurance Administration, the Supreme Law and the Central Commission for Discipline Inspection have deepened the management of pharmaceutical bribery In addition to the National Health and Health Commission, the State Health Insurance Administration, the Supreme Law and the Central Commission for Discipline Inspection have all worked on continuing to deepen the management of commercial bribery in the field of medicine.
    September 16, the State Health Insurance Administration officially issued the "Guidance on the Establishment of a Medical Price and Credit Evaluation System" Medical Insurance Issue (2020) No. 34.
    The State Administration of Medical Insurance has established a list of medical prices and the list of matters of mis-recruitment, which includes acts contrary to good faith, such as commercial bribery of pharmaceuticals, tax-related violations, etc., and includes in the scope of evaluation of drug prices and credit for the acts listed by pharmaceutical companies.
    For different levels of disrepair of pharmaceutical enterprises, provincial centralized purchasing agencies may, according to the credit rating of pharmaceutical enterprises, respectively, take written reminders and warnings, relying on centralized procurement platforms to prompt buyers of risk information, restrict or suspend the relevant drugs or medical supplies hanging on the network, restrict or suspend the procurement of related drugs or medical supplies, disclosure of disinced information and other disposal measures.
    the National Health Insurance Administration, by the end of 2020, provinces should set up and implement a credit evaluation system for pharmaceutical recruitment, and ensure that medical institutions give priority to pharmaceutical companies with better credit ratings.
    The Price Recruitment Division of the State Health Insurance Administration, in response to a reporter's question on the credit evaluation system for pharmaceutical recruitment, said, "According to the statistics of the publicly available court judgment documents, more than half of the 100 compulsory drug enterprises in China between 2016 and 2019 were found to have given or indirectly given kickbacks, of which the most frequent enterprises involved in more than 20 cases in three years, the amount of rebates in a single case exceeded 20 million yuan."
    average sales expense rate of listed companies in China is more than 30%.
    September 17, the State Health Insurance Administration announced that the Supreme People's Court and the State Health Insurance Administration signed a Memorandum of Cooperation on the Exchange and Sharing of Information on Commercial Bribery Cases in the Pharmaceutical Sector.
    The two sides will establish a regular notification system for commercial bribery cases in the field of medicine, actively expand the use of judicial results in the field of commercial bribery in the field of medicine, jointly promote information exchange and sharing at all levels of the system, and continue to deepen cooperation in the management of commercial bribery in the field of medicine.
    September 18, the official website of the State Supervision Commission of the Central Commission for Discipline Inspection once again published a key message focusing on medical corruption - "The discipline inspection and supervision organs strengthen supervision in the medical field, keep a close eye on the risk points to cut off the chain of interests."
    article pointed out that the discipline inspection and supervision organs should be based on functional responsibilities, adhere to the problem-oriented, comprehensively comb the medical field integrity risk points and high-risk links, resolutely cut off the chain of corrupt interests in the medical field, and promote the medical industry to eliminate the evil spirit.
    , the Central Commission for Discipline Inspection has published several thematic articles since April, focusing on issues such as commercial bribery of pharmaceuticals and the sale of gold.
    On August 4th, an article published on the website of the State Supervision Commission of the Central Commission for Discipline Inspection pointed out that the information on the examination of investigations and the information on the punishment of the Party discipline and government affairs issued by the Local Commission for Discipline Inspection showed that since this year, the coverage of medical anti-corruption has been further expanded, from major public hospitals, to clinical trial institutions, medical research institutes, to township hospitals, community health service centers, the relevant staff have been included in the scope of strict inspection.
    article combed found that in the first half of this year disclosed in the medical field corruption cases, the collection of drug supplies rebates is the most frequent problem, the amount involved in the case remains high, the chain of corrupt interests is chained together.
    at least until the end of the year, the nationwide medical clean-up and anti-corruption campaign will continue, and continued multi-sectoral efforts and interventions will make this round of medical clean-up more severe than in the past.
    the industry in recent times related news has decreased, but pharmaceutical companies, pharmaceutical representatives still can not be taken lightly.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.